Royce & Associates Amends MLAB Stake (10th Amendment)

Ticker: MLAB · Form: SC 13G/A · Filed: Jan 23, 2024 · CIK: 724004

Mesa Laboratories Inc /Co/ SC 13G/A Filing Summary
FieldDetail
CompanyMesa Laboratories Inc /Co/ (MLAB)
Form TypeSC 13G/A
Filed DateJan 23, 2024
Risk Levellow
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: institutional-ownership, amendment, passive-investing

Related Tickers: MLAB

TL;DR

**Royce & Associates just updated their MLAB stake, signaling a portfolio adjustment.**

AI Summary

Royce & Associates, LP, an investment firm, filed an amended Schedule 13G/A on January 23, 2024, indicating a change in their ownership of Mesa Laboratories, Inc. (MLAB) common stock as of December 31, 2023. This is their 10th amendment to their initial filing. While the filing doesn't specify the exact change in share count or percentage, the amendment suggests a notable adjustment in their holdings. This matters to investors because significant changes in institutional ownership can signal shifts in confidence or strategy regarding the stock.

Why It Matters

Changes in institutional ownership, especially from a long-term holder like Royce & Associates, can influence investor sentiment and potentially impact Mesa Laboratories' stock price.

Risk Assessment

Risk Level: low — This filing is a routine update on institutional ownership and does not inherently indicate a high-risk event for the company.

Analyst Insight

Investors should monitor subsequent filings or news from Royce & Associates, LP to understand the specific nature of their change in holdings and consider if it aligns with their own investment thesis for Mesa Laboratories, Inc.

Key Players & Entities

  • Royce & Associates, LP (company) — the investment firm filing the SC 13G/A
  • Mesa Laboratories, Inc. (company) — the subject company whose stock is being reported
  • December 31, 2023 (date) — the date of the event requiring the filing
  • January 23, 2024 (date) — the filing date of the SC 13G/A
  • 59064R109 (other) — CUSIP number for Mesa Laboratories, Inc. Common Stock

FAQ

What type of filing is this document?

This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as stated in the 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G (Rule 13d-102) ... (Amendment No.10)' sections.

Who is the reporting person in this filing?

The reporting person is Royce & Associates, LP, as indicated under 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ROYCE & ASSOCIATES LP'.

What is the subject company whose securities are being reported?

The subject company is Mesa Laboratories, Inc. /CO/, as stated under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MESA LABORATORIES INC /CO/' and 'Mesa Laboratories, Inc. (Name of Issuer)'.

What was the date of the event that triggered this filing?

The date of the event which required the filing of this statement was December 31, 2023, as specified in the filing.

How many amendments has Royce & Associates, LP filed for this particular Schedule 13G?

This is the 10th amendment (Amendment No.10) to their Schedule 13G filing for Mesa Laboratories, Inc., as noted in the 'SCHEDULE 13G ... (Amendment No.10)' section.

Filing Details

This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 23, 2024 regarding MESA LABORATORIES INC /CO/ (MLAB).

View full filing on EDGAR

View Full Filing

View this SC 13G/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.